Monday , July 13 2020
Home / Project Syndicate / Globalizing the Fight Against the Pandemic

Globalizing the Fight Against the Pandemic

Summary:
As a global problem that will remain a threat everywhere as long as it is still present anywhere, the novel coronavirus demands a collective and collaborative response. With a new COVID-19 Technology Access Pool to share data and intellectual property, all countries and companies now have a chance to become a part of the solution. SAN JOSÉ – The COVID-19 pandemic began less than six months ago, but we have already learned a great deal about the disease. Scientists around the world are looking at new and improved methods of detecting the novel coronavirus as early as possible. And in addition to these lines of inquiry, there are already eight potential vaccines under clinical evaluation, and more than 100 vaccine

Topics:
Carlos Alvarado Quesada considers the following as important:

This could be interesting, too:

[email protected] (Cyril Morong) writes Texas reverses course, says it won’t collect overpaid unemployment benefits in instances when it was the state’s mistake

Menzie Chinn writes An Improved GDP Outlook from Wall Street

Miles Kimball writes The Federalist Papers #12: Union Makes it Much Easier to Get Tariff Revenue—Alexander Hamilton

Menzie Chinn writes Lessons from the Past (i.e., the Last Recession)

As a global problem that will remain a threat everywhere as long as it is still present anywhere, the novel coronavirus demands a collective and collaborative response. With a new COVID-19 Technology Access Pool to share data and intellectual property, all countries and companies now have a chance to become a part of the solution.

SAN JOSÉ – The COVID-19 pandemic began less than six months ago, but we have already learned a great deal about the disease. Scientists around the world are looking at new and improved methods of detecting the novel coronavirus as early as possible. And in addition to these lines of inquiry, there are already eight potential vaccines under clinical evaluation, and more than 100 vaccine candidates in preclinical stages.

All of this represents extraordinary progress that we should celebrate. But there is reason to worry that not everyone will benefit from these breakthroughs. Developing...

Leave a Reply

Your email address will not be published. Required fields are marked *